Phaeospelide B

Details

Top
Internal ID 7d0413f7-1931-4623-8030-10a9c1dac290
Taxonomy Phenylpropanoids and polyketides > Macrolides and analogues
IUPAC Name (5E,7E,9E,11E,13E,15E,18S,20S,21E,24S,25E,28S,30S,32S)-18,20,24,28,30-pentahydroxy-32-methyl-1-oxacyclodotriaconta-5,7,9,11,13,15,21,25-octaen-2-one
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C32H46O7/c1-26-23-31(37)25-30(36)21-16-19-27(33)18-15-20-29(35)24-28(34)17-13-11-9-7-5-3-2-4-6-8-10-12-14-22-32(38)39-26/h2-13,15-16,19-20,26-31,33-37H,14,17-18,21-25H2,1H3/b4-2+,5-3+,8-6+,9-7+,12-10+,13-11+,19-16+,20-15+/t26-,27-,28-,29+,30-,31+/m0/s1
InChI Key COXPULGEPBOWHK-VPEHCZEFSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C32H46O7
Molecular Weight 542.70 g/mol
Exact Mass 542.32435380 g/mol
Topological Polar Surface Area (TPSA) 127.00 Ų
XlogP 5.30
Atomic LogP (AlogP) 4.31
H-Bond Acceptor 7
H-Bond Donor 5
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Phaeospelide B

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7838 78.38%
Caco-2 - 0.8247 82.47%
Blood Brain Barrier - 0.6750 67.50%
Human oral bioavailability - 0.5286 52.86%
Subcellular localzation Mitochondria 0.6253 62.53%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8692 86.92%
OATP1B3 inhibitior + 0.9607 96.07%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.9622 96.22%
P-glycoprotein inhibitior + 0.6424 64.24%
P-glycoprotein substrate - 0.7685 76.85%
CYP3A4 substrate + 0.5615 56.15%
CYP2C9 substrate - 0.8423 84.23%
CYP2D6 substrate - 0.8649 86.49%
CYP3A4 inhibition - 0.6414 64.14%
CYP2C9 inhibition - 0.8948 89.48%
CYP2C19 inhibition - 0.8773 87.73%
CYP2D6 inhibition - 0.9525 95.25%
CYP1A2 inhibition - 0.7365 73.65%
CYP2C8 inhibition - 0.8332 83.32%
CYP inhibitory promiscuity - 0.9654 96.54%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.8928 89.28%
Carcinogenicity (trinary) Non-required 0.6659 66.59%
Eye corrosion - 0.9172 91.72%
Eye irritation - 0.9185 91.85%
Skin irritation + 0.5205 52.05%
Skin corrosion - 0.7978 79.78%
Ames mutagenesis - 0.5000 50.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8499 84.99%
Micronuclear - 0.7900 79.00%
Hepatotoxicity + 0.5889 58.89%
skin sensitisation - 0.8366 83.66%
Respiratory toxicity + 0.7000 70.00%
Reproductive toxicity - 0.5189 51.89%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity + 0.6487 64.87%
Acute Oral Toxicity (c) III 0.6349 63.49%
Estrogen receptor binding + 0.7581 75.81%
Androgen receptor binding - 0.5344 53.44%
Thyroid receptor binding - 0.5535 55.35%
Glucocorticoid receptor binding - 0.4756 47.56%
Aromatase binding - 0.5953 59.53%
PPAR gamma + 0.6161 61.61%
Honey bee toxicity - 0.7599 75.99%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity + 0.5900 59.00%
Fish aquatic toxicity - 0.5625 56.25%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.30% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.85% 95.56%
CHEMBL1951 P21397 Monoamine oxidase A 86.27% 91.49%
CHEMBL3137262 O60341 LSD1/CoREST complex 85.93% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.64% 100.00%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 83.59% 99.23%
CHEMBL253 P34972 Cannabinoid CB2 receptor 82.52% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 81.01% 96.09%
CHEMBL2581 P07339 Cathepsin D 80.05% 98.95%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 146683205
LOTUS LTS0139211
wikiData Q104967362